ClinicalTrials.gg
CompletedNCT04457843Updated Apr 30, 2025

The Mobile COPD Status Test (mCST)

An observational study in Chronic Obstructive Pulmonary Disease, sponsored by Schön Klinik Berchtesgadener Land. Completed at 2 sites in Germany. Open to participants aged 40 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-04-30.

Sponsored by Schön Klinik Berchtesgadener Land · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
130
Ages
40 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 36 studies in Pulmonary Disease, Chronic Obstructive by Schön Klinik Berchtesgadener Land — none open to participants now, 1 under way, none of them phase 3. Pulmonary Disease, Chronic Obstructive · Schön Klinik Berchtesgadener Land.

Started
2020
with 2 others
Observational
5 of 36
none open now
Registered
35th of 36
by date

Among the 36 studies in Pulmonary Disease, Chronic Obstructive by Schön Klinik Berchtesgadener Land, this one is one of 3 that started in 2020, is one of 5 observational ones, and was the 35th registered.

Pulmonary Disease, Chronic Obstructive

5,529 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 858 are open to participants now.

Browse Pulmonary Disease, Chronic Obstructive studies →

Open to participants now

None of the 36 studies in Pulmonary Disease, Chronic Obstructive by Schön Klinik Berchtesgadener Land is open now. The open studies under Pulmonary Disease, Chronic Obstructive, anywhere →

Where they have run

Who these studies take

Of the 560 Pulmonary Disease, Chronic Obstructive studies recruiting now, 307 (55%) set no upper age limit and 82 (15%) stop at 75 or younger; 30 take children under 18; 88 take healthy volunteers.

This study: 40 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 36 studies in Pulmonary Disease, Chronic Obstructive by Schön Klinik Berchtesgadener Land as a file.
02

Study summary

Up tp now, disease activity of COPD patients in their home environment has usually been recorded by questionnaires (e.g. COPD assessment test). Digital multifactorial measurements, via the "mobile COPD Status test" app, offer a new way of displaying disease activity. However, there is no independent study that has examined whether digitally collected parameters correlate with the common used measurement instruments for COPD patients (both in cross-sectional and longitudinal course).

The aim of this exploratory study is to investigate the correlation between the mobile COPD Status test (mCST App, KAIA Health) and a conventional collected clinical data set of routine measurements as well as the subjective symptoms and activity perception of COPD patients in their home environment, with and without exacerbation.

Read the detailed description

In total 130 COPD patients will be included prospectively in this multicenter trial during an inpatient pulmonary rehabilitation program at the Schoen Klinik Berchtesgadener Land, Schönau am Koenigssee, (Germany) or during a stay (inpatient or outpatient) at the Klinikum Nuremberg (Germany).

In general, the study is divided into two parts - study part I, within the duration of the pulmonary rehabilitation program/ hospital stay and study part II, in the home environment (24 weeks).

Study part I:

Visit 1 (day 0, in the clinic) + Visit 2* (day 14+/-5, in the clinic/outpatient)

Each study participant is given a smartphone. Under the guidance of study personnel, data collection of the following parameters is carried out via KAIA mCST App):

  • four standardized questions regarding coughing frequency, expectoration, chest tightness and shortness of breath during exercise
  • Dyspnea at rest
  • Breath sounds via microphone
  • Inspiration/expiration length via microphone
  • Respiratory rate via smartphone measurements
  • Physical performance via the sit-to-stand test (1min) with counting the repetitions and checking the correct execution via smartphone camera
  • Gait analysis (2x 10 steps walking) via acceleration sensors of the smartphone or via motion tracking by camera during defined gait measurements.

The mCST app takes about 15 minutes to complete.

Additionally, clinical routine data will be collected:

  • medical history
  • body plethysmography \& blood gases
  • EKG
  • health related quality of life
  • dyspnea
  • 6-minute walk distance
  • 1-minute-sit to stand test

Study part II:

Visits 3 to 26 (week 3 to 26, in participants home environment) From study visit 3 on, participants are observed weekly in their home environment for a total of 24 weeks. No further clinic visits take place. Disease activity is measured weekly as patient reported outcomes using the mCST app (for details see description of visit 1/2, part 1). In addition to the weekly mCST app, patients are invited to fill out daily a symptom diary before going to bed. The symptom diary contains the EXACT questionnaire and an activity questionnaire.

*Visit 2 is optional

03

Conditions studied

  • Chronic Obstructive Pulmonary Disease

Keywords

  • Telehealth
  • disease progression
  • disease activity
04

Who can participate

Ages eligible
40 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

COPD patients

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • hospitalisation at Schoen Klinik Berchtesgadener Land or Klinikum Nuremberg
  • GOLD A-D
  • sufficient german language and samrtphone skills to understand the mCST app
  • sufficient good WLAN Connection in the domestic environment

Exclusion criteria

Exclusion Criteria:

  • presence of comorbidities which could interfere the course of the trial (e.g. cognitive deficits, neurological or orthopedic diseases)
  • significant mental illness, legal incapacity or limited legal capacity
  • patients who are unable or unwilling to perform the study activities acording to the protocol
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
130 participants (actual)
Patient registry
No

Groups and cohorts

  • COPD patients

    Other: usual medical care

Interventions

  • Otherusual medical care

    Prospective monitoring of clinical Outcomes and digital collected outcomes via the mobile COPD staus test app.

06

What researchers measure

Primary outcomes

  1. Correlation between usual physical exercise tests and exercise test measured via mobile COPD status test app (mCST)

    Correlation between the 6-minute walk test distance (clinical routine) and the number of repetitions of the 1-minute sit-to-stand-test (mCST app)

    Time frame: Visit 1 (Day 0)

  2. Correlation between usual physical exercise tests and exercise test measured via mobile COPD status test app (mCST)

    Correlation between the 6-minute walk test distance (clinical routine) and the number of repetitions of the 1-minute sit-to-stand-test (mCST app)

    Time frame: if applicable Visit 2 (Day 14)

Secondary outcomes

  1. Correlation between COPD Assessment test and perception of disease activity measured via mobile COPD status test app (mCST)

    Correlation between standardized questions about COPD activity/ symptoms via the mCST app and the COPD Assessment Test

    Time frame: weekly up to 26 weeks (Visit 1 to Visit 26)

  2. Correlation between modified medical research scale (mMRc) and perception of dyspnea measured via mobile COPD status test app (mCST)

    Correlation between standardized questions about dyspnea collected via the mCST app and the modified medical research scale

    Time frame: Visit 1 (Day 0)

  3. Correlation between modified medical research scale (mMRc) and perception of dyspnea measured via mobile COPD status test app (mCST)

    Correlation between standardized questions about dyspnea collected via the mCST app and the modified medical research scale

    Time frame: if applicable Visit 2 (Day 14)

  4. Correlation between lung function parameters and inspiratory-/expiratory duration measured via mobile COPD status test app (mCST)

    Correlation between inspiratory-/ expiratory duration via the mCST app and FEV1, RV, TLC, VC

    Time frame: Visit 1 (Day 0)

  5. Correlation between lung function parameters and inspiratory-/expiratory duration measured via mobile COPD status test app (mCST)

    Correlation between inspiratory-/ expiratory duration via the mCST app and FEV1, RV, TLC, VC

    Time frame: if applicable Visit 2 (Day 14)

  6. Correlation between mCST app and symptom diary (EXACT questionnaire)

    Correlation between standardized questions about COPD activity/symptoms via the mCST app and the EXACT questionnaire, which consists of 14 questions to quantify exacerbations.

    Time frame: weekly up to 26 weeks (Visit 1 to Visit 26)

  7. Correlation between mCST app and symptom diary (Freiburger activity questionnaire)

    Correlation between standardized questions about COPD activity/ symptoms via the mCST app and the Freiburger activity questionnaire, which consists of 12 items and measures the duration and frequency of various basic, everyday and sports activities of the past week

    Time frame: weekly up to 26 weeks (Visit 1 to Visit 26)

  8. Differences in outcomes of the mobile COPD status test app (mCST) between patients without and with exacerbations during the study period

    Change in the mCST app parameters during the trial period in stable COPD patients an COPD patients with an acute exacerbations during the study period

    Time frame: weekly up to 26 weeks (Visit 1 to Visit 26)

07

Study locations

2 sites
  • Klinikum Nürnberg, Klinik für Innere Medizin3, Schwerpunkt Pneumologie
    Nürnberg, Germany
  • Klinikum Berchtesgadener Land, Schön Kliniken
    Schönau am Königssee, 83471, Germany
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2020 to primary completion in Jul 2023, 35 months.

Of 469 non-industry observational studies under Pulmonary Disease, Chronic Obstructive, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 62. This study's 35 months is above that.

Counting every sponsor, half of 589 studies reached it within 26 months; a quarter within 14 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 4, 2020
First posted
Jul 7, 2020
StartActual
Aug 21, 2020
Primary completionActual
Jul 31, 2023
CompletionActual
Jul 31, 2023
Last update
Apr 30, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04457843
Lead sponsor
Schön Klinik Berchtesgadener Land
Responsible party
Prof. Dr. Andreas Rembert Koczulla (Professor for pulmonary rehabilitation, Schön Klinik Berchtesgadener Land) — Principal investigator
First posted
Jul 7, 2020
Start date
Aug 21, 2020
Primary completion
Jul 31, 2023
Completion
Jul 31, 2023
Last update
Apr 30, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion